NUTRINERVE
ABOUT NUTRINERVE

Provide Nutrition announces the introduction of NutriNerve 2.2 by NeuroEffex. This nutritional supplement is specifically formulated to support nerve health.* NutriNerve contains a proprietary and patent pending balance of Alpha Lipoic Acid, Benfotiamine and Gamma-Linolenic Acid. Please review the research articles for these key ingredients to understand more about what the medical research community is saying about these ingredients.

Supporting the Body against Neuropathy The ingredients in NutriNerve have been shown to improve neuropathy symptoms by improving the underlying biology of the patient. This goes beyond simply relieving the symptoms of neuropathy.

Key Ingredient Summary Information

Alpha Lipoic Acid (ALA) has been shown in placebo controlled randomized studies to improve diabetic neuropathy symptoms. In the SYDNEY 2 trial, there was demonstrated to be a 52% decrease in Total Symptom Score (including pain, paresthesia, and asleep numbness of the feet) after five weeks of 600 mg ALA (1). ALA is also attributed with a 44% increase in vasodialation of the brachial artery(2).

Gamma Linolenic Acid (GLA) has been shown to restore nerve conduction velocity in rats that that have had a 25% decrease in nerve conduction velocity due to diabetes(3).

Benfotiamine A statistically significant (p = 0.0287) improvement in the neuropathy score was observed in the group given benfotiamine(4).

Click for Supporting Medical Research Studies

The NeuroEffex Continuity Program

All of our products are available via continuity programs. By default, every 60 days (unless you specify otherwise or decide to alter your dose at some point in the future) your credit card is debited for the product and it is shipped to you. You can cancel at any time by calling 1-800-344-9993 or emailing us at customerservice@neuroeffex.com.

In addition we have a money back guarantee if you return an unopened bottle within 30 days of purchase. If your physician is not currently a NeuroEffex provider, but later becomes one, you can call at some future point and update your account with his/her HRN and your future shipments will receive the 10% discount. Finally, you can call or email and delay your next shipment by any number of days, weeks or months if you find yourself with extra product at some point in the future. If you need to raise or lower your dose, please see our FAQ about how to correctly adjust the arrival and shipping schedule of your purchase or simply call 1-800-344-9993. Our associates can help you adjust the frequency of your shipments so they arrive in time to maintain the prescribed dose. Again you can cancel at anytime.

Safety

The NutriNerve manufacturing plants, processes, and ingredients meet and or exceed federal guidelines, regulations and requirements. Our plant is cGMP certified and is certified by the Natural Products Association. It is also has received a Drug Manufacturing License from the California State Health Department, Food and Drug Branch and is registered with the FDA as a drug manufacturing establishment. We meet the highest standards in the industry. If you have more questions about the quality of our product, please speak with us directly or contact us via email.

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

(1)Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.Diabetes Care. 2006 Nov;29(11):2365-70

(2)Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation. 2005 Jan 25;111(3):343-8. Epub 2005 Jan 17.

(3)Beneficial effects of gamma linolenic acid supplementation on nerve conduction velocity, Na+, K+ ATPase activity, and membrane fatty acid composition in sciatic nerve of diabetic rats.J Nutr Biochem. 1999 Jul;10(7):411-20.

(4)Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study). Int J Clin Pharmacol Ther. 2005 Feb;43(2):71-7.